Search Login Register

Orbital Pseudotumor Summary

Description: A nonspecific tumor-like inflammatory lesion in the ORBIT of the eye. It is usually composed of mature LYMPHOCYTES; PLASMA CELLS; MACROPHAGES; LEUKOCYTES with varying degrees of FIBROSIS. Orbital pseudotumors are often associated with inflammation of the extraocular muscles (ORBITAL MYOSITIS) or inflammation of the lacrimal glands (DACRYOADENITIS).

Also Known As: Granuloma, Plasma Cell, Orbital; Inflammatory Pseudotumor of Orbit; Orbital Granuloma, Plasma Cell; Orbital Inflammatory Pseudotumor; Plasma Cell Granuloma, Orbital Show All >>

Networked: 81 relevant articles (8 outcomes, 2 trials/studies) for this Disease

Key Drugs and Agents for Orbital Pseudotumor

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Adrenal Cortex Hormones (Corticosteroids) : 3 outcomes in 12 results : IBA
  2. Immunoglobulins (Immunoglobulin) : 1 outcome 1 study in 4 results : IBA
  3. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor) : 1 outcome in 1 result : IBA
  4. Methylprednisolone : 1 outcome in 1 result : FDA 18 Generic
  5. Cytotoxins : 1 outcome in 1 result : IBA
  6. C-Reactive Protein : 1 outcome in 1 result : IBA
  7. Azathioprine (Imuran) : 1 outcome in 1 result : FDA 7 Generic
  8. Antinuclear Antibodies : 1 outcome in 1 result : IBA
  9. infliximab (Remicade) : 1 outcome in 1 result : FDA 2
  10. iodonitrotetrazolium (INT) : 1 outcome in 1 result : IBA
Show All >>

Diseases Related to Orbital Pseudotumor

  1. Inflammation
  2. Polyneuropathies (Polyneuropathy)
  3. Pseudolymphoma
  4. Neoplasms (Cancer)
  5. Sclerosing Cholangitis
Show All >>

Key Therapies for Orbital Pseudotumor

Efficacy Chart >>
  1. Radiotherapy : 3 outcomes in 5 results
  2. Thymectomy : 1 outcome in 1 result
  3. Biological Therapy : 1 outcome in 1 result
  4. Drug Therapy (Chemotherapy) : 3 results
  5. Aftercare (After-Treatment) : 3 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.